Velocity Clinical Research

Formerly known as Impact Research Institute

Velocity Clinical Research is the world’s leading organization of clinical research sites. They partner with pharmaceutical and biotechnology companies to research new drugs, medical devices and diagnostics that could improve human health.

Their Waco location was founded as Impact Research Institute and acquired by Velocity in 2023. Led by Nadege Gunn, MD, CPI, they conduct trials for many therapeutic areas, including obesity, diabetes, vaccines, gastroenterology and internal medicine, with extensive experience in liver diseases like MASH and MASLD (formerly known as non-alcoholic fatty liver disease or NAFLD) — unhealthy amounts of fat in the liver.

Join a study with Velocity. Beyond helping advance medicine, you may also learn about potential new medicines in development, get study-related medical exams at no cost and receive compensation for participating. Visit VelocityClinical.com.

Velocity Clinical Research

6600 Fishpond Rd., Ste 103